102767-31-7 (左乙拉西坦杂质A,(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide)

左乙拉西坦杂质A;(S)-N-(1-氨基-1-酮代-2-丁基)-4-氯代丁酰胺;((S)-N-(1-氨基-1-氧代丁-2-基)-4-氯丁酰胺);(S)-N-(1-氨基-1-氧代丁-2-基)-4-氯丁酰胺;(S)-n-(1-氨基-1-氧代丁烷-2-基)-4-氯丁酰胺;醋氯芬酸乙酯;左乙拉西坦相关物质A;左乙拉西坦相关物质A USP标准品;左乙拉西坦杂质3;5-二丙基氨基-Α,Α,Α-4,6-二硝基-邻-甲苯胺;氨基丙乐灵;左乙拉西坦杂质E;N-[(1S)-1-(氨基羰基)丙基]-4-氯丁酰胺;左乙拉西坦USP RC A;

Levetiracetam Related Compound A;(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide;(2S)-2-(4-chlorobutanoylamino)butanamide;Levetiracetam USP RC A;Levetiracetam Impurity E;(S)-N-[1-(AMinocarbonyl)propyl]-4-chlorobutanaMide;N-[(1S)-1-(AMinocarbonyl)propyl]-4-chlorobutanaMide;Levetiracetam Related Compound A (20 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide);102767-31-7;J-000782;SCHEMBL5836749;3P8M8S76NM;N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide, (-)-;Levetiracetam Impurity 3;N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide, (S)-;Butanamide, N-((1S)-1-(aminocarbonyl)propyl)-4-chloro-;AKOS027320653;UNII-3P8M8S76NM;(S)-N-[1-(aminocarbonyl)propy]-4-chlorobutanamide;DTXSID10145496;DTXCID4067987;DB-224822;F19522;Q27257856;Butanamide, N-[(1S)-1-(aminocarbonyl)propyl]-4-chloro-;

MFCD09955129

QBJNYRYTZPBHFT-LURJTMIESA-N

1S/C8H15ClN2O2/c1-2-6(8(10)13)11-7(12)4-3-5-9/h6H,2-5H2,1H3,(H2,10,13)(H,11,12)/t6-/m0/s1

ClCCCC(N[C@H](C(N)=O)CC)=O

13476773